Parsiyel Nefrektomi Sonrası Saptanan Anjiyomiyolipomun Nadir Bir Varyantı, Epiteloid Anjiyolipom
Anjiyomiyolipomlar (AML) üç ana yapıdan (vasküler, düz kas ve olgun yağ doku) oluşan benign renal tümörler olarak kabul edilir. AML'nin bileşenlerinin, böbrek mezenkiminin baskılanmamış ve anormal farklılaşmasından kaynaklandığı düşünülmektedir. AML, tüm renal tümörlerin % 2.0- 6.4'ünü oluşturur. Çoğu AML asemptomatiktir görülme sıklığı yaklaşık 10.000 yetişkinde 13'tür. AML’lerin %80’i sporadik, %20’si tüberoz skleroz kompleksinin (TSK) bir parçası olarak gözlenir. Bir AML çeşidi olan Epiteloid AML (EAML), renal hücreli karsinom (RHK) ile karışabilen bir tümör olup benign veya malign (metastaz,nüks) seyredebilen bir tümör çeşididir. EAML görüntülemede de RHK ile karışabilen bir kitledir.Bu nedenle, immünohistokimya olmaksızın RHK’dan ayırıcı tanı yapmak zordur. Biz size 34 yaşında, Bilgisayarlı Tomografide (BT) 11,5 cm renal kitle görülen ve hastaya yapılan parsiyel nefrektomi sonrası patolojide EAML saptanan vakamızı sunuyoruz.
Epithelioid Angiomyolipoma, A Rare Variant of Angiomyolipoma detected After Partial Nephrectomy
Angiomyolipomas (AML) are described as benign renal tumors which consist of vascular, smooth muscle, and adipose tissue components. Abnormal differentiation of renal mesenchyme is the main reason. It forms only 2-6,4% of the whole renal tumors, but it is the most common among the benign tumors. Most of them are asymptomatic and we can see it in almost 13 of 10.000 adults. Eighty percent of the AML is sporadic and 20% of them can be seen as a part of tuberous sclerosis complex (TSC). Epithelioid AML (EAML) is a rare subtype that can have malign or benign progression, it can be misdiagnosed as Renal Cell Carcinoma (RCC) and it is hard to differentiate them. EAML have some common diagnostic characteristics in presentations with other renal tumors. Because of that, we need to make an immunohistochemical examination to differentiate it from RCC, especially. We presented a 34 years old female patient with the pathologic result of the EAMLin the partial nephrectomy material.
___
- 1. Park HK, Zhang S, Wong MK, Kim HL. Clinical presentation of epithelioid angiomyolipoma. Int J Urol 2007; 14: 21-5.
- 2. Celik S, Comez K, Bozkurt O et al. Renal Epithelioid Angiomyolipoma: Two Case Reports and Review of the Literature. Bulletin of Urooncology 2015; 14: 330-332.
- 3. Eble JN. Angiomyolipoma of kidney. Semin Diagn Pathol 1998; 15: 21-40.
- 4. Mete O, van der Kwast TH. Epithelioid angiomyolipoma: a morphologically distinct variant that mimics a variety of intra-abdominal neoplasms. Arch Pathol Lab Med 2011; 135: 665- 70.
- 5. Aydin H, Magi-Galluzzi C, Lane BR et al. Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association. Am J Surg Pathol 2009; 33: 289-97.
- 6. Huang KH, Huang CY, Chung SD, Pu YS, Shun CT, Chen J. Malignant epithelioid angiomyolipoma of the kidney. J Formos Med Assoc 2007; 106: S51-4.
- 7. Halpenny D, Snow A, McNeill G, Torreggiani WC. The radiological diagnosis and treatment of renal angiomyolipoma-current status. Clin Radiol 2010; 65: 99-108.
- 8. Zhu J, Li H, Ding L, Cheng H. Imaging appearance of renal epithelioid angiomyolipoma: A case report and literature review. Medicine (Baltimore) 2018; 97: e9563.
- 9. Liulytė A, Žalimas A, Meškauskas R, Ušinskienė J, Jankevičius F. Partial nephrectomy can be a successful treatment option for renal epithelioid angiomyolipoma: a case report and literature review. Acta Med Litu 2020; 27: 33-8.
- 10. Cibas ES, Goss GA, Kulke MH, Demetri GD, Fletcher CD. Malignant epithelioid angiomyolipoma ('sarcoma ex angiomyolipoma') of the kidney: a case report and review of the literature. Am J Surg Pathol 2001; 25: 121-6.